Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Mimedx (MDXG) over the last 6 years, with Q3 2025 value amounting to -$5.8 million.

  • Mimedx's Deferred Taxes fell 10502.67% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year decrease of 13249.82%. This contributed to the annual value of -$12.5 million for FY2024, which is 13299.3% down from last year.
  • Mimedx's Deferred Taxes amounted to -$5.8 million in Q3 2025, which was down 10502.67% from -$287000.0 recorded in Q2 2025.
  • Mimedx's 5-year Deferred Taxes high stood at $37.8 million for Q4 2023, and its period low was -$5.8 million during Q3 2025.
  • Moreover, its 3-year median value for Deferred Taxes was -$2.2 million (2024), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Mimedx's Deferred Taxes plummeted by 10616.37% in 2024, and later skyrocketed by 9459.1% in 2025.
  • Quarter analysis of 3 years shows Mimedx's Deferred Taxes stood at $37.8 million in 2023, then crashed by 106.16% to -$2.3 million in 2024, then crashed by 146.82% to -$5.8 million in 2025.
  • Its Deferred Taxes stands at -$5.8 million for Q3 2025, versus -$287000.0 for Q2 2025 and -$621000.0 for Q1 2025.